Continuous Data Monitoring and AI-assisted Predictive Medicine “better” for Diabetes Care, Says Clinic

Continuous Data Monitoring and AI-assisted Predictive Medicine “better” for Diabetes Care, Says Clinic

The Dubai-based GluCare Integrated Diabetes Center has published a second set of clinical results revealing further reduction of haemoglobin A1c (HbA1c) levels in its patients.

Remote continuous data monitoring – a personalised, tech-focused approach to diabetes management employed by one Dubai-based specialist clinic – continues to demonstrate positive results in its patients, it has been confirmed.

Six months since the release of its first report showcasing preliminary outcomes of its care model, GluCare Integrated Diabetes Center has now published a second set of clinical results revealing further reduction of haemoglobin A1c (HbA1c) levels in its patients.

Appearing in the journal Diabetes Management, the clinic’s latest results show that those undergoing treatment reduced their HbA1c levels by an average of 2.14% over 90 days.

In April, results showed an average HbA1c reduction of 1.7%.




Next Article

Did you find this useful?

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.


© 2024 Netspective Media LLC. All Rights Reserved.

Built on Apr 19, 2024 at 8:35am